by alexcastillo | May 13, 2021 | MAT Resources
The New Mexico Medical Advisory Team (MAT) Vaccine Safety and Efficacy Workgroup has reviewed the relevant documents related to the Pfizer-BioNTech COVID-19 vaccine as provided by the manufacturer, the U.S. Food and Drug Administration (FDA), and the U.S. Centers for...
by alexcastillo | Mar 3, 2021 | MAT Resources
The Medical Advisory Team (MAT) Vaccine Safety and Efficacy Workgroup has reviewed the relevant documents related to the Janssen Ad26.COV2.S COVID-19 vaccine as provided by the manufacturer, the U.S. Food and Drug Administration (FDA), and the U.S. Centers for Disease...
by alexcastillo | Dec 21, 2020 | MAT Resources
The Medical Advisory Team (MAT) Vaccine Safety and Efficacy Workgroup has reviewed the relevant documents related to the Moderna mRNA-1273 vaccine as provided by the manufacturer, the U.S. Food and Drug Administration (FDA), and the U.S. Centers for Disease Control...
by alexcastillo | Dec 18, 2020 | MAT Resources
The Medical Advisory Team (MAT) Vaccine Safety and Efficacy Work group has revised its recommendation to include additional guidance on the management of vaccine supply, including the full use of multi-dose vial contents that may contain more than 5 doses per vial....
by alexcastillo | Sep 3, 2020 | MAT Resources
The Mat defines predicted increases in need for behavioral health services during and after the pandemic; defines existing capacity and needed expansion of that capacity; and, outlines needed capacity expansion in an actionable format. Download this...
